RPRX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

बेचें 844 min ago

@ $28.54

जारी किया गया: 7 May 2024 @ 19:02

वापसी: -0.91%

पिछला सिग्नल: May 7 - 00:42

पिछला सिग्नल: खरीदें

वापसी: 0.30 %

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 01:30):

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States...

Stats
आज की मात्रा	2.39M
औसत मात्रा	2.83M
बाजार मूल्य	12.75B
EPS	$0 ( 2024-02-15 )
अगली कमाई की तारीख	( $0.960 ) 2024-05-09
Last Dividend	$0.200 ( 2023-11-16 )
Next Dividend	$0 ( N/A )
P/E	11.18
ATR14	$0.485 (1.72%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Fernandez Henry A	Buy	1 240	Class A Ordinary Shares
2024-03-28	Bassler Bonnie L	Buy	1 240	Class A Ordinary Shares
2024-02-20	Riggs Rory B	Buy	300 000	Class A Ordinary Shares
2024-02-20	Riggs Rory B	Sell	30 000	LP interests in RPI US Partners 2019, LP
2024-01-02	Riggs Rory B	Sell	235 200	Class A Ordinary Shares

INSIDER POWER
-36.00
Last 100 transactions
Buy: 3 308 362 \| Sell: 7 318 226

मात्रा सहसंबंध

लंबा: 0.94 (very strong)

छोटा: -0.63 (weak negative)

Signal:(58) Neutral

Royalty Pharma plc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
INCR	0.957
MYSZ	0.939
SPFI	0.937
BMRA	0.933
WATT	0.931
CUTR	0.93
CSSEP	0.925
BWB	0.919
EVLO	0.918
TIVC	0.918

10 सबसे अधिक नकारात्मक सहसंबंध
ESCA	-0.946
AMTBB	-0.945
BRLI	-0.945
GRIL	-0.944
ARIZ	-0.941
CNGL	-0.94
GBRG	-0.936
LQDA	-0.934
EMLD	-0.934
LMRKO	-0.93

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Royalty Pharma plc सहसंबंध - मुद्रा/वस्त्र

0.86
( strong )

0.88
( strong )

0.00
( neutral )

0.91
( very strong )

-0.30
( neutral )

-0.61
( weak negative )

Royalty Pharma plc वित्तीय

Annual	2023
राजस्व:	$2.35B
सकल लाभ:	$1.79B (76.19 %)
EPS:	$2.54

FY	2023
राजस्व:	$2.35B
सकल लाभ:	$1.79B (76.19 %)
EPS:	$2.54

FY	2022
राजस्व:	$2.24B
सकल लाभ:	$2.23B (99.75 %)
EPS:	$0.0978

FY	2021
राजस्व:	$2.29B
सकल लाभ:	$0.00 (0.00 %)
EPS:	$0.922

Financial Reports:

No articles found.

Royalty Pharma plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.190 (N/A)	$0.190 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Royalty Pharma plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.40 - Stable (27.94%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2020-09-14
Last Dividend	$0.200	2023-11-16
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	$2.54	--
Avg. Dividend % Per Year	1.17%	--
Score	4.72	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.40
Div. Directional Score	8.70	--

Next Divdend (Est)
(2024-07-01)

$0.205 Estimate 38.46 %

Dividend Stability

0.77 Good

Dividend Score

4.72

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2020	$0.300	0.67%
2021	$0.680	1.45%
2022	$0.760	1.93%
2023	$0.800	2.03%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.482	1.500	0.360	0.540	[0 - 0.5]
returnOnAssetsTTM	0.0693	1.200	7.69	9.23	[0 - 0.3]
returnOnEquityTTM	0.182	1.500	9.09	10.00	[0.1 - 1]
payoutRatioTTM	0.316	-1.000	6.84	-6.84	[0 - 1]
currentRatioTTM	7.90	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.87	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.96	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.375	-1.500	3.76	-5.64	[0 - 0.6]
interestCoverageTTM	7.98	1.000	8.15	8.15	[3 - 30]
operatingCashFlowPerShareTTM	6.70	2.00	7.77	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.964	2.00	9.02	10.00	[0 - 20]
debtEquityRatioTTM	0.940	-1.500	6.24	-9.36	[0 - 2.5]
grossProfitMarginTTM	0.697	1.000	1.719	1.719	[0.2 - 0.8]
operatingProfitMarginTTM	0.634	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.488	1.000	8.40	8.40	[0.2 - 2]
assetTurnoverTTM	0.144	0.800	-2.38	-1.900	[0.5 - 2]
Total Score				11.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.21	1.000	8.97	0	[1 - 100]
returnOnEquityTTM	0.182	2.50	9.41	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.964	2.00	9.35	10.00	[0 - 30]
dividendYielPercentageTTM	2.84	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.70	2.00	7.77	10.00	[0 - 30]
payoutRatioTTM	0.316	1.500	6.84	-6.84	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	1.271	1.000	10.00	0	[0.1 - 0.5]
Total Score				6.40

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

के लिए वास्तविक समय के अद्यतन Royalty Pharma plc [RPRX]

Upcoming Earnings Alert

Royalty Pharma plc Dividend Information - Dividend Knight

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)